Nanotechnology Conference and Trade Show - Nanotech 2006
> Program > Technical Conferences > Business & Development > Nano Impact Workshop > Nanotech Job Fair > Expo
Program
Sessions
Sunday
Monday
Tuesday
Wednesday
Thursday
Index of Authors
Index of Keywords
Confirmed Speakers
Conferences & Symposia

Conference Proceedings

Conference Technical Proceedings

Mediating Multiple, Same Family GPCRs with Single, Multi-Target PEPDUCIN® Drug Compounds

J. Cosmopoulos
Tufts University, US

Keywords:
GPCR, cancer, inflammation, thrombosis

Abstract:
PEPDUCIN compounds constitute a novel class of drug compounds. T-NEMC has pursued an aggressive patent strategy with broad composition of matter claims, directed to PEPDUCIN compounds based on any GPCR intra-cellular domain or loop attached to any lipid moiety, and broad methods of use claims. There are pending patent applications in the US, EPO, Japan, Canada and Australia. This IP estate is expected to dominate any third parties that may to wish to practice in the PEPDUCIN field.

The first U.S. patent issued on March 8, 2005 with broad claims directed to any PEPDUCIN compound any third GPCR intra-cellular attached to any lipid moiety.

A US trademark application for the “PEPDUCIN” mark has also been registered.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors

Nanotech 2006 Conference Program Abstract

 
Nanotechnology Conference | Terms of use | Privacy policy | Contact | NSTI Home
Program | Technical Conferences | Business & Development | Nano Impact Workshop | Nanotech Job Fair | Expo |
Nanotech 2006 Home | Press Room | Venue | Subscribe | Site Map
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.